| Introduction | Balsm Alofoq Medical Co. announces the Board of Directors’ decision dated 04/29/1447 AH corresponding to 10/21/2025 AD to recommend to the Extraordinary General Assembly to increase the company’s capital by (100%) by granting free shares through capitalizing an amount of (10,150,000) ten million one hundred and fifty thousand riyals from the balance of the issuance premium and an amount of (2,350,000) two million three hundred and fifty thousand riyals from the retained earnings account by granting (1) free share for every (1) share owned by shareholders |
| Date of Board Meeting | 2025-10-21 Corresponding to 1447-04-29 |
| Capital before increase | 12,500,000 |
| Capital after increase | 25,000,000 |
| Percentage of Capital increase | 100 % |
| Number of shares before Capital increase | 1250000 |
| Number of shares after Capital increase | 2500000 |
| Reasons for the increase | The company aims to increase its capital to enhance its strategic growth plan, future expansion needs and aspirations, and to confirm its financial suitability and the strength of its financial position. |
| Number of Shares Granted per Exiting Share | One (1) share will be granted to each shareholder who owns one (1) share. |
| Nature and Value of Reserves Used in the Capitalization | The increase will be made by capitalizing an amount of (10,150,000) ten million one hundred and fifty thousand riyals from the issue premium balance and an amount of (2,350,000) two million three hundred and fifty thousand riyals from the retained earnings account. |
| Eligibility Date | Eligible Shareholders are Those Holding Shares in the Eligibility Date as per the Shareholders Registry at the Deposit Center at The End of The Second Working Day after Eligibility Date |
| Fractional Shares | In the event of fractional shares, the fractions will be collected in one portfolio for all shareholders and sold at the market price, then their value will be distributed to the shareholders entitled to the bonus, each according to his share, within a period not exceeding 30 days from the date of determining the shares due to each shareholder. |
| Approvals | The grant is conditional upon obtaining the approvals of the official authorities and the extraordinary general assembly for the increase in capital and the number of shares granted. |
